研究单位：[1]China-Japan Friendship Hospital[2]Aerospace Center Hospital[3]Beijing Chao Yang Hospital[4]Cangzhou Central Hospital of Tianjin Medical University[5]Civil Aviation General Hospital[6]Dongguan Tungwah Hospital[7]Emergency General Hospital[8]Fifth Affiliated Hospital of Xinjiang Medical University[9]First Central Hospital of Tianjin[10]Fuwai Yunnan Cardiovascular Hospital[11]Guangdong Provincial People's Hospital[12]Henan Provincial Chest Hospital[13]Ningbo No. 1 Hospital[14]Peking University People's Hospital[15]Peking University Shougang Hospital[16]People's Hospital of Xinjiang Uygur Autonomous Region[17]Second Hospital of Tianjin Medical University[18]Shaoxing People's Hospital[19]Shengjing Hospital[20]First Affiliated Hospital of Xinjiang Medical University[21]the First Affiliated Hospital, Harbin Medical University[22]Zhejiang University[23]People's Hospital of Guangxi[24]The Third People's Hospital of Chengdu[25]Tianjin Medical University General Hospital[26]Tianjin Union Medicine Center[27]Tongji Hospital[28]West China Hospital[29]Xuanwu Hospital, Beijing[30]Wuhan University[31]China-Japan Friendship Hospital,Beijing,Beijing,China,100029
Coronary artery disease (CAD) is the leading cause of death in end-stage renal disease (ESRD) patients requiring dialysis. There are limited data on clinical characteristics, treatment strategies and outcomes in this special patient population in China. As a nationwide, observational, multicenter cohort study, this study consecutively included ESRD patients on dialysis with significant CAD at 30 tertiary care centers in 12 provinces in China from January 2015 to June 2021. Patient data collected included demographics, comorbidities, cardiac history, cardiac function, location and severity of CAD, procedural information, medications, and clinical events.
